Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legend Biotech
LEGN
|
+$145M |
| 2 |
Immatics
IMTX
|
+$43.5M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
+$38.6M |
| 4 |
Coca-Cola
KO
|
+$35.8M |
| 5 |
Caesars Entertainment
CZR
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$78.3M |
| 2 |
ACLX
Arcellx
ACLX
|
+$57.6M |
| 3 |
Royalty Pharma
RPRX
|
+$52.8M |
| 4 |
AT&T
T
|
+$50.3M |
| 5 |
UnitedHealth
UNH
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.9% |
| 2 | Consumer Discretionary | 8.93% |
| 3 | Technology | 8.81% |
| 4 | Financials | 5.59% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Bristol-Myers Squibb
BMY
$137B
| $1.91M | 0.07% |
+33,800
| New | +$1.89M |
|
77
Natera
NTRA
$47.9B
| $1.6M | 0.05% |
10,100
| – | – |
|
78
Stryker
SYK
$126B
| $1.57M | 0.05% |
4,360
| – | – |
|
79
Avantor
AVTR
$9.78B
| $1.51M | 0.05% |
71,850
| – | – |
|
80
IQVIA
IQV
$42.8B
| $1.41M | 0.05% |
7,175
| – | – |
|
81
Medtronic
MDT
$119B
| $1.39M | 0.05% |
17,460
| – | – |
|
82
Waters Corp
WAT
$40.4B
| $1.17M | 0.04% |
3,150
| – | – |
|
83
McKesson
MCK
$100B
| $1.04M | 0.04% |
1,830
| – | – |
|
|
LKFT
84
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $1.02M | 0.03% |
37,111
-10,089
| -21% | -$281K |
|
85
Elevance Health
ELV
$86.9B
| $1.01M | 0.03% |
+2,740
| New | +$1.15M |
|
86
HCA Healthcare
HCA
$92.9B
| $957K | 0.03% |
3,190
| – | – |
|
87
Edwards Lifesciences
EW
$51.8B
| $822K | 0.03% |
11,100
| – | – |
|
88
Agilent Technologies
A
$44.9B
| $670K | 0.02% |
4,990
| – | – |
|
89
Veralto
VLTO
$24.1B
| $558K | 0.02% |
5,475
| – | – |
|
90
ResMed
RMD
$33.4B
| $547K | 0.02% |
2,390
| – | – |
|
91
Ionis Pharmaceuticals
IONS
$9.93B
| $378K | 0.01% |
10,800
| – | – |
|
92
Zimmer Biomet
ZBH
$19.3B
| $344K | 0.01% |
3,260
| – | – |
|
93
Steris
STE
$23.2B
| $315K | 0.01% |
1,530
| – | – |
|
94
PACS Group
PACS
$7.01B
| $262K | 0.01% |
20,000
| – | – |
|
95
Baxter International
BAX
$13.6B
| $232K | 0.01% |
7,970
| – | – |
|
96
Align Technology
ALGN
$11.5B
| $229K | 0.01% |
1,100
| – | – |
|
|
97
Apple
AAPL
$4.51T
| – | – |
-336,147
| Closed | -$78.3M |
|
|
ACLX
98
DELISTED
Arcellx
ACLX
| – | – |
-689,950
| Closed | -$57.6M |
|
99
Alnylam Pharmaceuticals
ALNY
$31.6B
| – | – |
-13,824
| Closed | -$3.8M |
|
|
CNTA
100
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-70,000
| Closed | -$1.12M |
|
Similar funds
Aaron Cowen's Q4 2024 Portfolio in Review
As of Q4 2024, Aaron Cowen held 115 positions worth $2.93B, down 6.1% from $3.13B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Aaron Cowen's Q4 2024 filing shows 17 new, 19 increased, 24 reduced and 19 closed positions. Its largest new stake was Legend Biotech: 3,496,234 shares worth $114M. The largest sale was Apple, an estimated $78.3M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Consumer Discretionary and Technology.
- Aaron Cowen's largest Q4 2024 buy was Legend Biotech: 3,496,234 shares worth $114M.
- Aaron Cowen added most to Coca-Cola in Q4 2024, an estimated $35.8M increase.
- Aaron Cowen's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $40.7M.
- Aaron Cowen fully exited Apple in Q4 2024, selling an estimated $78.3M.
- Aaron Cowen's ten largest holdings make up 44% of its $2.93B portfolio in Q4 2024.
- Aaron Cowen opened 17 new positions and closed 19 in Q4 2024.
- Aaron Cowen's portfolio value fell 6.1% quarter-over-quarter to $2.93B.
Based on Suvretta Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.